×
0.00225988700564987 0.0096045197740114 0.0141242937853107 0.0209039548022599 0.0220338983050848 0.0344632768361584 0.036723163841808 0.0406779661016951
Stockreport

NewLink Genetics: Initiating Coverage With Buy Rating And First Price Target = $24 (Multiple Upcoming Catalysts) [Seeking Alpha]

NEWLINK GENETICS (NLNK)  More Company Research Source: Seeking Alpha
Last newlink genetics earnings: 11/2 08:00 am Check Earnings Report
PDF Summary NewLink Genetics (NASDAQ: NLNK ) is Ames, Iowa, based emerging biotechnology company in the field of immuno-oncology. The company's common stock sank last year after the failure of two Phase 3 trials of its HyperAcute cellular immunotherapy in metastatic pancreatic cancer. Afterwards, the stock more than doubled from its 2016 lows in anticipation of data from its IDO inhibitor pipeline and has pulled back from the recent highs, thus providing an attractive long entry point. (NewLink Genetics, common stock price chart. Source: Bloomberg) Product Pipeline: (NewLink Genetics, IDO inhibitor immuno-oncology product pipeline) The company's immuno-oncology pipeline is focused on the inhibition of IDO (indoleamine-2, 3-dioxygenase) pathway which is believed to be an immune checkpoint similar to PD-1 and CTLA-4 pathways. It is one of the handful of companies which are developing IDO inhibitors (and the one of two public ones). The IDO pathway r [Read more]

IMPACT SNAPSHOT EVENT TIME: NLNK
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS